PCA3 Responsive Molecular Imaging Enables Spatial Visualization of Prostate Cancer
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
PCA3 is an established prostate cancer biomarker. Here, we investigated its use as a molecular trigger for fluorescence activation and spatial visualization of prostate cancer. We developed CaS-DNA, an RNA-responsive molecular beacon that activates the near-infrared fluorophore indocyanine green upon PCA3 recognition. CaS-DNA showed sequence-specific hybridization and target-dependent fluorescence activation, with signal intensity strongly correlating with PCA3 expression across prostate cancer cell models (R = 0.96) and minimal activation in non-malignant controls. Selective labeling was maintained in spatially defined co-cultures and prostate cancer xenografts. In freshly resected human prostate tissue, CaS-DNA fluorescence corresponded with histopathologically defined tumor regions and showed tumor-coverage comparable to PSMA-targeted molecular imaging. Spatial transcriptomic analysis demonstrated concordance between CaS-DNA fluorescence and tumor-associated transcriptional profiles, while heterogeneous fluorescence was associated with local differences in transcript abundance. CaS-DNA converts endogenous PCA3 expression into spatially resolved near-infrared fluorescence, providing a molecularly guided approach for prostate cancer visualization and assessment.
